Generated from latest updates
AI Daily Brief
Two payers published first-ever Dawnzera policy this week — both landed with step therapy against Takhzyro. Tryngolza (sHTG) gained a favorable TG-threshold simplification at Aetna; FCS genetic-testing criteria still needs source confirmation at three plans.